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http://dx.doi.org/10.1016/j.ccell.2017.04.004SUMMARYPolyploidy can lead to aneuploidy and tumorigenesis. Here, we report that the Hippo pathway effector Yap
promotes the diploid-polyploid conversion and polyploid cell growth through the Akt-Skp2 axis. Yap strongly
induces the acetyltransferase p300-mediated acetylation of the E3 ligase Skp2 via Akt signaling. Acetylated
Skp2 is exclusively localized to the cytosol, which causes hyper-accumulation of the cyclin-dependent ki-
nase inhibitor p27, leading to mitotic arrest and subsequently cell polyploidy. In addition, the pro-apoptotic
factors FoxO1/3 are overly degraded by acetylated Skp2, resulting in polyploid cell division, genomic insta-
bility, and oncogenesis. Importantly, the depletion or inactivation of Akt or Skp2 abrogated Hippo signal defi-
ciency-induced liver tumorigenesis, indicating their epistatic interaction. Thus, we conclude that Hippo-Yap
signaling suppresses cell polyploidy and oncogenesis through Skp2.INTRODUCTION
Polyploidy is a state in which cells possess more than two sets
of homologous chromosomes. Although it is less frequently
found in animals, some tissues, including the liver, have a highSignificance
p53 is required for the induction of cell senescence to limit the
deficiency or Yap activation in mouse livers result in polyploid
Hippo signals and p53 lead to greatly increased polyploidy and
We revealed that Yap induces cell polyploidy through the Skp
deregulation of the Hippo-Yap-Skp2 axis is found in a substan
po-Yap signaling acts as an alternative polyploid checkpoint, t
vision, thus limiting the risk of genomic instability, aneuploidypercentage of polyploid cells. Polyploid hepatocytes undergo
ploidy reversal to specifically generate unique hepatocytes
with different mixtures of chromosomes (Duncan, 2013; Gentric
and Desdouets, 2014; Pandit et al., 2013). This genetic diversity
may be an adaptive mechanism, serving as a means for theproliferation of polyploid cells. We found that Hippo signal
formation and polyploid cell growth. The combined loss of
result in a higher incidence and earlier onset of liver tumors.
2-mediated ubiquitin-proteasome pathway. Importantly, the
tial fraction of human hepatocellular carcinomas. Thus, Hip-
ogether with p53, to synergistically restrain polyploid cell di-
, and tumorigenesis.
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Figure 1. Yap Activation Increases Hepatocyte Polyploidy and Synergizes with p53 Inactivation to Enhance Liver Tumorigenesis
(A and B) Fluorescence-activated cell sorting (FACS) analysis (A) and the DNA content quantification (B) of polyploid hepatocytes from wild-type (WT),
WW45f/fAlb-Cre (WW45 KO),Mst1f/fMst2f/fAlb-Cre (Mst1/2 DKO), Lats1f/fLats2f/fAlb-Cre (Lats1/2 DKO), Yap (S127A) transgenic (Yap Tg), and Yapf/fAlb-Cre (Yap
KO) mice (n = 3). 2C, 4C, 8C, and >8C DNA content, corresponding to diploid, tetraploid, octaploid, and higher polyploid hepatocytes, respectively.
(legend continued on next page)
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selection of hepatocytes most resistant to xenobiotic or
nutritional injury. Gene redundancy shields polyploids from the
deleterious effects of mutations (Duncan et al., 2009, 2010).
However, polyploid cells precede aneuploid cells that give rise
to increased genomic instability and tumor progression (Davoli
and de Lange, 2011; Ganem and Pellman, 2007; Gordon
et al., 2012). Consistently, two-thirds partial hepatectomy (PH)-
induced liver regeneration results in increased cell polyploidy
and causes the normally quiescent polyploid hepatocytes to un-
dergo cell-cycle re-entry and division, accelerating the ability of
oncogenes to induce hepatocellular carcinoma (HCC) (Beer
et al., 2004). Polyploid cells are normally arrested in theG1 phase
of the cell cycle, thus preventing genomic instability, aneuploidy,
and tumorigenesis. Thus, it is of particular interest to determine
the mechanisms regulating polyploid formation and polyploid
cell division.
Cell polyploidy can result from cell fusion or abnormal cell di-
vision, including endoreduplication, mitotic slippage and cytoki-
nesis failure (Pandit et al., 2013). Cytokinesis failure and mitotic
slippage events have a pivotal role in establishing hepatocyte
polyploidy (Celton-Morizur et al., 2009; Hsu et al., 2016; Pandit
et al., 2012). Skp2 is a major cytokinetic regulator and an
F box protein that targets p27 for ubiquitination and subsequent
degradation to promote cell-cycle progression (Carrano et al.,
1999; Nakayama et al., 2000, 2004). Skp2-null mice develop a
phenotype of polyploidy and centrosome amplification in the
liver (Kossatz et al., 2004; Nakayama et al., 2004; Serres et al.,
2012). Elevated levels of p27 in the S and G2/M phases upon
the depletion of Skp2 cause cytokinesis failure and mitotic slip-
page events. These phenotypes are completely rescued by the
concomitant deletion of p27 (Nakayama et al., 2004). Recent
studies revealed that Skp2 stability, sub-cellular localization,
and activity are regulated by its phosphorylation and acetylation
(Chan et al., 2012; Gao et al., 2009; Inuzuka et al., 2012; Lin et al.,
2009). Skp2 expression is highly upregulated in a variety of hu-
man cancers (Calvisi et al., 2009; Lee et al., 2015; Lin et al.,
2010;Wang et al., 2010; Zhao et al., 2013). These results indicate
that certain signaling may be required for the regulation of Skp2
function in controlling cell polyploidy.
The Hippo signaling pathway is a critical regulator of stem cell
self-renewal, tissue regeneration, and organ size (Johnson and
Halder, 2014; Pan, 2010; Yu et al., 2015). Central to this pathway
is a kinase cascade formed by mammalian sterile20 kinases
Mst1 and Mst2 (Mst1/2), a scaffolding protein Salvador/WW45(C) Hepatocytes in liver sections from the indicated genotypes were labeled with
DAPI-positive compartment (nucleus) were imaged with a Zeiss LSM 780 (upper
(D and E) The correlation of hepatocyte size and ploidy status from WT mice a
YapS127A was assessed by immunofluorescent staining (D) and FACS (E) approa
(F and G) The quantification of the percentage of cells at the different mitotic pha
immunohistochemistry (IHC) staining for pHH3 in liver sections.
(H) Immunoblot analysis of p53, phosphorylated (p-) Yap, Yap, Mst1, Mst2, and
(I) Immunoblot analysis of p53, Yap, and GAPDH in WT or Yap Tg liver tissues.
(J) The DNA content quantification of polyploid hepatocytes from WT, Mst1/2 DK
(K) A representative liver picture and the liver-to-body weight ratios (n = 5) of 2-m
(K and L) A representative liver picture (K) and the quantification of the size and n
Mst1/2 p53 TKO mice.
(M) A proposed working model for Hippo signaling decreases hepatocyte polypl
Data were assessed by Student’s t test and represented asmean ± SD. ns, not sig
See also Figure S1.(Sav), an NDR family kinases large tumor suppressor 1 (Lats1)
and Lats2, and an adaptor protein Mob1.Mst1/2 phosphorylates
and activates Lats1/2-Mob1, which then phosphorylates the
yes-associated protein (Yap) or WW domain-containing tran-
scription regulator protein 1 (Taz). Phospho-Yap/Taz is either
degraded or sequestered in the cytoplasm by 14-3-3 protein.
When the Hippo pathway is inactivated, Yap/Taz translocates
to the nucleus and forms a functional hybrid transcriptional fac-
tor with TEA domain family members to turn on pro-proliferative
and pro-survival genes, enabling cell proliferation. The Hippo
pathway also mediates crosstalk with other signaling pathways
including the phosphoinositol-3-kinase (PI3K)-Akt pathway (Du-
pont et al., 2011; Heallen et al., 2011; Tumaneng et al., 2012; Yu
et al., 2012). Genetic defects in this pathway in mice lead to
tissue overgrowth and cancer development in multiple organs
(Camargo et al., 2007; Dong et al., 2007; Zhou et al., 2009).
A recent study showed that Hippo signaling is highly activated
in polyploid cells (Ganem et al., 2014). p53 is normally required
for the induction of cellular senescence to limit polyploid cell
growth (Davoli et al., 2010; Fujiwara et al., 2005; Kurinna et al.,
2013). Lats2 kinase of the Hippo signaling pathway was reported
to stabilize p53 by inhibiting murine double minute 2 (Mdm2)
(Aylon et al., 2006; Iida et al., 2004), which resulted in tetraploid
cell-cycle arrest. Thus, polyploidy status might trigger Lats2
kinase to activate p53 to prevent polyploidy cell proliferation (Ga-
nem et al., 2014). Interestingly, Yap overexpression dramatically
increases hepatocyte polyploidy, suggesting that Yap is a down-
stream effector of Lats2 kinase in ploidy regulation (Ganem et al.,
2014). Recent studies have shown that Yap is phosphorylated by
cyclin-dependent kinase 1 (CDK1) and that this mitotic phos-
phorylation of Yap is required for the activation of the spindle
checkpoint in immortalized epithelial cells (Yang et al., 2013,
2015). However, the mechanism by which Yap determines cell
ploidy and chromosomal stability remains unclear. Genetic evi-
dence in animals supporting the central role of Hippo signaling
in polyploidy formation and subsequent neoplastic transforma-
tion is still largely lacking.
RESULTS
Loss of Hippo Signaling Promotes Hepatocyte
Polyploidy
Hepatocytes are either mononucleated or binucleated, and
each nucleus is diploid, tetraploid, octaploid, or higher, whichDAPI and an antibody against b-catenin. The areas of the cell (cell size) and the
panel) and quantified using ImageJ software (lower panel). Scale bars, 20 mm.
fter the hydrodynamic delivery of pCMV-mCherry control or pCMV-mCherry-
ches. Scale bars, 20 mm.
ses (F) and the percentage of abnormal anaphase cells (G) according H&E and
GAPDH in WT or Mst1/2 DKO liver tissues.
O, p53KO, or Mst1/2 p53 TKO mice using FACS analysis (n = 3).
onth-old WT, Mst1/2 DKO, p53KO, or Mst1/2 p53 TKO mice.
umber of liver tumors (n = 5) (L) of 4.5-month-old WT, Mst1/2 DKO, p53KO, or
oidy and synergizes with p53 to inhibit liver tumorigenesis.
nificant, *p < 0.05, **p < 0.01, ***p < 0.001 compared between indicated groups.
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Figure 2. Loss of Hippo Signaling Resulted in the Accumulation of p27 Leading to Polyploidy
(A) The quantification of the relative protein expression levels of cell-cycle-related proteins p27, p21, CDK2, CDK4, CDK6, Cyclin A1, Cyclin D1, and Cyclin E1 in
livers from the indicated mouse strains with a liver-specific mutation of the Hippo signaling components.
(B) qPCR analysis of the p27 mRNA expression in hepatocytes from the indicated liver-specific mutant mice.
(C) Immunoblot analysis of p27, p-Yap, Yap, Lats1, Lats2, and GAPDH in WT or Lats1/2 DKO MEFs.
(D) Immunoblot analysis of p27, Yap, and GAPDH in WT, Yap Tg, or Yap KO control liver tissues.
(E) Immunoblot analysis of p27, Yap, Mst1, Mst2, and GAPDH in WT, Mst1/2 DKO, Yap+/flAlb-Cre (YAP+/–), or Mst1f/fMst2f/f Yap+/flAlb-Cre (DKO Yap+/–) liver
tissues.
(legend continued on next page)
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makes the liver a valuable organ in which to study cell ploidy
regulation. To characterize the function of Hippo signaling on
hepatocyte ploidy, we determined the hepatocyte ploidy and
nuclear size in liver tissues isolated from various mouse strains
with a liver-specific mutation for Hippo signaling components.
Compared with wild-type (WT) mice, hepatocytes in the livers
of WW45f/fAlb-Cre (WW45 knockout [KO]), Mst1f/fMst2f/fAlb-
Cre (Mst1/2 double knockout [DKO]), Lats1f/fLats2f/fAlb-Cre
(Lats1/2 DKO), or doxycycline-inducible active Yap (S127A)
transgenic (Yap Tg) mice exhibited markedly enlarged nuclear
size and increased cell polyploidy, whereas Yapf/fAlb-Cre
(Yap KO) animals showed smaller nuclear size and reduced
cell polyploidy in the liver (Figures 1A, 1B, S1A, and S1B). In
addition, we found that cells of different genotypes with larger
nuclei have larger cell sizes (Figure 1C). Furthermore, immu-
nofluorescent staining and flow cytometric analysis clearly
showed that Yap transgenic hepatocytes had an increased
DNA content and greater cell size (Figures 1D and 1E). These
results demonstrated that Hippo signaling plays a critical role
in ploidy regulation.
We also found that the loss of Mst1/2 or the overexpression of
Yap-induced supernumerary centrosomes and abnormal mitotic
spindle formation in dividing hepatocytes (Figures S1C and
S1D). In addition, during the regeneration process after PH,
more dividing cells at prophase and metaphase were found in
Mst1/2 DKO livers than in WT livers (Figures 1F and S1E).
Furthermore, fewer cells but with a higher incidence of abnormal
anaphase were found in Mst1/2 DKO livers, indicating that cyto-
kinesis failure occurs in Mst1/2 DKO livers (Figure 1G). These
data demonstrated that Hippo signaling is important for ensuring
accurate centrosome duplication and chromosome segregation
to maintain genome stability.
p53 is normally required to induce G1 arrest and cellular
senescence in response to tetraploidy or missegregated chro-
mosomes. Lats2 kinase of the Hippo signaling pathway was pre-
viously reported to activate and stabilize p53 (Aylon et al., 2006).
Surprisingly, we found that the p53 protein levels were dramati-
cally increased in the livers of WW45KO, Mst1/2 DKO, Lats1/2
DKO, and Yap Tgmice comparedwith those inWT livers (Figures
1H, 1I, S1F, and S1G). We speculated that the highly increased
p53 protein levels might be the result of a potent negative feed-
back loop in response to increased cell polyploidy upon the
disruption of Hippo signals. Indeed, the loss of p53 in Mst1/2
DKO (Mst1/2 p53 TKO) mice led to a larger nuclei size and higher
polyploidy numbers than those in their Mst1/2 DKO littermates
(Figures 1J, S1H, and S1I). Mst1/2 p53 TKO mice also exhibited
increased ratios of liver/body weight and accelerated liver tumor
formation compared withWT, p53 KO, or Mst1/2 DKOmice (Fig-(F–H) H&E staining of liver sections (F, upper panel) and the quantification of cell nu
of polyploid hepatocytes by FACS from WT or Mst1/2 DKO mice infected with ei
shRNA (Ad-Shp27) as indicated (n = 3). Scale bars, 20 mm.
(I and J) IHC staining of BrdU or pHH3 in the liver sections fromWT, Mst1/2 DKO, o
partial hepatectomy (I). The bar graph shows the quantifications of BrdU- or pHH
(K) Immunoblot analysis of the p27 levels in the livers from Mst1/2 DKO mice infec
(L and M) A representative liver picture (L) and the quantification of the size and n
AAV-GFP or AAV-Shp27 (M).
(N) A proposed working model for Yap activation promoting nuclear accumulatio
Data were assessed by Student’s t test and represented as mean ± SD. ns, not s
groups. See also Figure S2.ures 1K, 1L, and S1J). Taken together, these results indicated
that Yap activation increases hepatocyte polyploidy and syner-
gizes with p53 inactivation to enhance liver tumorigenesis
(Figure 1M).
Hippo Signal Deficiency Induces Polyploidy via p27
Polyploidy may occur due to cell fusion or abnormal cell division.
To identify the potential cell-cycle regulators that induce hepato-
cyte polyploidy from various mouse strains with liver-specific
mutations of the Hippo signaling pathway, we analyzed the pro-
tein expression profile of cell-cycle-related proteins, i.e., CKIs
(p27 and p21), CDKs (CDK2, CDK4, and CDK6), and cyclins
(Cyclin A1, Cyclin D1, and Cyclin E1). We found that only the
expression level of p27 was consistently increased in primary
hepatocytes from WW45 KO, Mst1/2 DKO, Lats1/2 DKO, and
Yap(S127A) Tg mice, but it was decreased in hepatocytes from
Yap KO animals (Figures 2A, S2A, and S2B), indicating that
p27 might be a direct target downstream of the Hippo signaling
pathway. Interestingly, unlike its protein levels, the p27 mRNA
level was reduced in Hippo signaling-deficient livers suggesting
that theHippo signalingmight regulate the protein stability of p27
(Figure 2B). The positive correlation of p27 levels with Yap activ-
ity was further confirmed in primary mouse embryonic fibro-
blasts (MEFs) isolated from WT, Lats1/2 DKO, Yap(S127A) Tg,
or Yap KO mice (Figures 2C–2E), and one Yap allele deletion in
Mst1/2 DKO liver (Mst1/2 DKO Yap+/-) was sufficient to reduce
the level of the p27 protein to the level in normal WT hepatocytes
(Figures 2E and S2C). These data indicated that Hippo signaling
controls the protein level of p27.
Previous studies showed that elevated p27 could cause a
failure to enter mitosis and thereby induce polyploidy (Kossatz
et al., 2004; Nakayama et al., 2004). We next sought to deter-
mine whether the p27 hyper-accumulation is responsible for
increased polyploidy in hepatocytes with a Hippo signaling defi-
ciency. Indeed, the ablation of p27 using adenoviral short hairpin
RNA (shRNA) (Ad-Shp27) (Figures S2D and S2E) in Hippo
signaling-deficient livers or MEF cells resulted in decreased he-
patocyte polyploidy and smaller nuclear size (Figures 2F–2H,
S2F, and S2G). To determine whether the hyper-accumulation
of p27 results in a failure to enter mitosis, we assessed the
DNA synthesis rate and mitosis events in Mst1/2-deficient hepa-
tocytes after a PH. Compared with the WT liver, the Mst1/2 DKO
liver had a dramatically higher number (approximately 4-fold) of
bromodeoxyuridine (BrdU)-positive (DNA synthesis phase) he-
patocytes, but a moderately higher level (approximately 2-fold)
of phospho-histone H3 (pHH3)-positive (mitosis phase) hepato-
cytes, indicating that a high fraction of polyploid cells in Mst1/2
DKO liver were arrested in mitosis, whereas the knockdown ofmber per view field (G) or the DNA content quantification (F, lower panel, and H)
ther adenovirus expressing a GFP control vector (Ad-GFP) or p27-knockdown
rMst1/2 DKOmice infected with either Ad-GFP or Ad-Shp27 as indicated after
3-positive cells in the livers (n = 3) (J). Scale bars, 20 mm.
ted with adeno-associated virus (AAV) expressing control GFP or p27 shRNA.
umber of liver tumors in 4.5-month-old Mst1/2 DKO mice (n = 4) infected with
n of p27 resulted in increased polyploidy and tumor formation.
ignificant, *p < 0.05, **p < 0.01, ***p < 0.001 compared between the indicated
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Figure 3. Loss of Hippo Signaling Enhances the Cytoplasmic Retention of Skp2
(A and B) Immunoblot analysis of p27, Skp2, a-tubulin, or PARP in the cytoplasmic (c) and nuclear (n) fractions of WT, Mst1/2 DKO (A) or Yap Tg (B) liver tissues.
(C and D) IHC staining (C) or immunoblot analysis of the cell fractions (D) of Skp2 and p27 in liver tissues fromWT, Mst1/2 DKO,Mst1f/fMst2f/f Yap+/flAlb-Cre (DKO
Yap+/–), or Yap Tg mice. Scale bars, 20 mm.
(E) Immunofluorescent staining of Skp2 (red) and the nuclear counterstain (DAPI, blue) in primary MEFs isolated fromWT, Lats1/2 KO (left panel), or Yap Tg (right
panel) mice. Scale bars, 10 mm.
(F–H) Immunoblot analysis of acetylated (ace-) Skp2, Skp2, p-Yap, Yap, Mst1, Mst2, and GAPDH in the immunoprecipitates or total lysates of hepatocytes
isolated from WT, Mst1/2 DKO (F), Yap Tg (G), or Yap KO (H) mice. For the detection of ace-Skp2, the loading of the immunoprecipitates was normalized ac-
cording to the levels of total Skp2.
(I and J) Immunoassay assessing the ubiquitination of p27 (detected with anti-Myc) in the lysates of 293T cells expressing various combinations of Myc-tagged
ubiquitin, Flag-tagged p27, HA-tagged Yap, and HA-tagged WT Skp2 (I) or an acetylation-mimetic (KLKL) mutant form of Skp2 (J) as indicated.
(K) Immunoblot analysis of Skp2, p27, and GAPDH in liver tissues from WT and Skp2 KO mice infected with Ad-GFP, Ad-Skp2 (WT), or Ad-Skp2 (KLKL).
(L) A proposed working model for Yap activation regulating p27 stability through modulating Skp2 acetylation and sub-cellular localization.
See also Figure S3.
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Figure 4. Yap Regulates Skp2 Cytoplasmic Retention via the Akt-p300 Axis
(A–C) Immunoblot analysis of p-p300, p300, p-Akt, Akt, Yap, or GAPDH in the immunoprecipitates or total lysates of hepatocytes isolated fromWT, Mst1/2 DKO
(A), Yap Tg (B), or Yap KO (C) mice. For the detection of the p-p300 levels, the loading of the immunoprecipitates was normalized according to the levels of
total p300.
(D and E) Immunoblot analysis of p27, Skp2, a-tubulin, or PARP in the cytoplasmic (c) and nuclear (n) fractions of liver cells isolated frommice treated with vehicle
or insulin (D) or mice infected with Ad-GFP or Ad-Myr-Akt1 (active Akt1) (E).
(F and G) FACS analysis (F) and the DNA content quantification (G) of ploidy hepatocytes from WT mice infected with Ad-GFP or Ad-Myr-Akt1 (n = 3).
(H) A representative liver picture and the liver-to-body weight ratios of WT mice (n = 5) infected with Ad-GFP or Ad-Myr-Akt1.
(I and J) Immunoblot analysis of the cell fractions (I) or IHC staining (J) of Skp2 and p27 from liver tissues isolated fromMst1/2 DKOmice treated with vehicle or the
Akt inhibitor MK2206. Scale bars, 20 mm.
(K) Immunoblot analysis of Skp2, p27, a-tubulin, or PARP in the cytoplasmic and nuclear fractions of liver tissues from WT, Akt1 KO, Mst1/2 DKO, or Mst1f/f
Mst2f/fAkt1 KO Alb-Cre (triple knockout [TKO]) mice.
(legend continued on next page)
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p27 in Mst1/2 DKO livers slightly increased the number of BrdU-
positive hepatocytes, but dramatically increased pHH3-positive
hepatocytes. This finding indicated that more cells entered
mitosis for proliferation and division (Figures 2I and 2J). Further-
more, we knocked down p27 expression in WT and Mst1/2 DKO
livers using adeno-associated virus (AAV), which can have a
long-term effect of up to 6 months. We found that knocking
down p27 in Hippo-deficient livers resulted in decreased cell
polyploidy and significantly reduced the number and volume of
tumor size at 5 weeks post-infection with AAV p27 shRNA
(Figures 2K–2M and S2H). We found similar results in
Mst1f/fMst2f/fAlb-Cre mice with one p27 allele deletion (Mst1/2
DKO p27+/) (Figures S2I–S2N). We further observed much
lower incidences of abnormal anaphase cells in the livers of
Mst1/2 DKO p27+/ mice than in Mst1/2 DKO livers, indicating
that p27 downregulation restored cellular cytokinesis to normal
levels in Mst1/2 DKO livers (Figures S2K and S2L). As themitosis
of polyploid cells leads to genomic instability and a higher inci-
dence of cancer formation, it is not surprising that we observed
that the loss of p27 resulted in a lower incidence and delayed tu-
mor formation in Hippo signal-deficient livers by reducing cell
polyploidy in the context of a much higher fraction of polyploid
cells in Mst1/2 DKO liver tissues, although p27 downregulation
increased the cell mitosis and proliferation of diploid cells (Fig-
ures 2L, 2M, S2M, and S2N). These results indicated that the
Hippo signaling pathway limits polyploidy formation and pre-
vents tumor formation, at least in part, through the downregula-
tion of p27 (Figure 2N).
Hippo Signaling Deficiency Enhances the Cytoplasmic
Retention of Skp2
Previous studies showed that S-phase kinase-associated protein
2 (Skp2) in the nuclear compartment is required for ubiquitin-
mediated p27 degradation. We measured the levels of Skp2 and
p27 in whole-cell lysates, and the cytoplasmic and nuclear frac-
tions from WT, Mst1/2 DKO, or Yap Tg hepatocytes, and found
that the protein levels of Skp2 and p27 were increased in whole-
cell lysates of Mst1/2 DKO or Yap Tg hepatocytes compared
with those inWTcells (FiguresS3AandS3B).However, thesepro-
teins were present in distinct sub-cellular locations (Figures 3A
and 3B). The cytoplasmic retention of Skp2 in Mst1/2 DKO or
Yap Tg livers was further confirmed by immunohistochemistry
(IHC) staining (Figures 3C and 3D) and was observed in primary
MEFs isolated from Lats1/2 DKO or Yap Tg mice (Figure 3E) and
a HepG2 cell line overexpressing Yap (Figure S3C). Furthermore,
the loss of one allele of Yap in Mst1/2 DKO hepatocytes restored
the nuclear localization of Skp2, thereby reducing the p27 levels
(Figures 3C and 3D). These data suggested that loss of Hippo
signaling resulted in the cytoplasmic retention of Skp2, leading
to the nuclear accumulation of p27. Previous studies showed
that the acetylation of Skp2 promotes its translocation from the
nuclei to the cytosol (Inuzuka et al., 2012). In line with its(L–O) H&E staining of liver sections (L and N, upper panel), the quantification of ce
(L and N, lower panel, M and O) of polyploid hepatocytes from Mst1/2 DKO mice
Mst1/2 DKO, or Mst1/2 Akt1 TKO mice (n = 3) (N and O). Scale bars, 20 mm.
(P) A proposed working model for Yap activation modulating Skp2 acetylation an
Data were assessed by Student’s t test and represented as mean ± SD. ns, not s
indicated groups. See also Figure S4.
676 Cancer Cell 31, 669–684, May 8, 2017sub-cellular localization, Skp2 acetylation levels were greatly
increased in Mst1/2 DKO and Yap Tg hepatocytes, and attenu-
ated in Yap KO hepatocytes (Figures 3F–3H). In addition, p27
ubiquitination was remarkably attenuated in cells overexpressing
Yap or an acetylation-mimetic mutant Skp2 (KLKL) that was
mainly located in the cytosol (Figures 3I and 3J). Consistently,
the p27 levels were greatly reduced in Skp2 KO livers infected
with adenoviruses expressingWT Skp2, but only slightly reduced
in Skp2 KO liver infected with acetylation-mimetic mutant Skp2
(Ad-Skp2 [KLKL]) (Figure 3K). These results indicated that Hippo
signaling regulates p27 stability through modulating Skp2 acety-
lation and sub-cellular localization (Figure 3L).
Yap Promotes Skp2 Cytoplasmic Retention and
Hepatocyte Polyploidy via the Akt-p300 Axis
It hasbeen reported thatYapactivates thePI3K-Akt pathway (Tu-
manenget al., 2012). Akt canphosphorylate andactivate the ace-
tyltransferases p300 to enhance Skp2 acetylation at both K68
and K71, which promotes Skp2 cytoplasmic translocation and
protein stability (Inuzuka et al., 2012). Indeed, the phosphoryla-
tion levels of Akt and p300 were attenuated in Yap KO cells, but
greatly increased in WW45 KO, Mst1/2 DKO, Lats1/2 DKO, and
Yap Tg hepatocytes (Figures 4A–4C, S4A, and S4B), in which
enhanced acetylation and cytoplasmic retention of Skp2 was
found (Figures 3F and 3G). A previous study showed that the
insulin signal activates the PI3K/Akt pathway to promote the
hepatocyte tetraploidization process (Celton-Morizur et al.,
2009). Interestingly, we found that insulin treatment resulted in
increased cytoplasmic Skp2 and nuclear p27 levels in the liver
cells, suggesting that insulin-mediated Akt activationmay induce
hepatocyte polyploidy by promoting the cytoplasmic retention of
Skp2 (Figures 4D, S4C, and S4D). To further validate this specu-
lation, we infectedWTmice with adenovirus expressing a consti-
tutively active myristoylated Akt1 (Ad-Myr-Akt1) or a control
Ad-GFP. To avoid fatty liver induced by myr-Akt overexpression
(Onoet al., 2003), the viruswas titrated and amoderate titer of the
virus was used. Comparedwith control animals infectedwith Ad-
GFP, mice infected with Ad-Myr-Akt1 exhibited enhanced acet-
ylation and cytoplasmic retention of Skp2 in hepatocytes, and
increased hepatocyte polyploidy and liver mass (Figures 4E–4H
and S4E). Furthermore, treatment with the Akt inhibitor MK2206
or thegenetic disruptionof Akt1 reduced theprotein levels of total
and cytoplasmic Skp2 and nuclear p27 in Mst1/2 DKO liver cells
(Figures 4I–4K and S4F–S4G), resulting in significantly reduced
hepatocyte polyploidy in Mst1/2 DKO mice (Figures 4L–4O).
Taken together, these data indicated that Hippo signaling con-
trols cell polyploidy through Akt-Skp2 signaling (Figure 4P).
Cytoplasmic Skp2 Potentiates Polyploidy Cell
Proliferation and Division
To further determine whether the cytoplasmic retention of
Skp2 is responsible for the high cell polyploidy profiles inll number per view field (M and O), or the DNA content quantification by FACS
treated with the Akt inhibitor MK2206 (n = 3) (L and M) or from WT, Akt1 KO,
d sub-cellular localization via Akt-P300 signaling.
ignificant (p > 0.05), *p < 0.05; **p < 0.01; ***p < 0.001 compared between the
Figure 5. Cytoplasmic Skp2 Promotes Polyploid Cell Division
(A) Immunoblot analysis of p27, Skp2, Mst1, Mst2, and GAPDH in liver lysates of WT, Skp2 KO, Mst1/2 DKO, or Mst1f/fMst2f/fSkp2 KO Alb-Cre (Mst1/2 Skp2
TKO) mice.
(B and C) H&E staining of the liver sections (B, upper panel) and the DNA content quantification of hepatocytes of the indicated mice using FACS (n = 3) (B, lower
panel), and (C). Scale bars, 20 mm.
(D and E) IHC staining (D) and the quantification (E) of BrdU- or pHH3-positive cells in the liver sections from the indicated mice. Scale bars, 20 mm.
(F and G) A representative liver picture and the liver-to-body weight ratios (n = 5, 3 months old) (F) and the quantification of liver tumors (n = 5, 5 months old) (G) of
the indicated mice.
(legend continued on next page)
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Hippo-deficient livers, we knocked out Skp2 in Mst1/2 or WW45
KOmice.We found that the loss of Skp2 inMst1/2 DKOorWW45
KO livers resulted in a slight increase in the p27 protein levels
(Figures 5A and S5A), but had no significant effect on the cell
polyploidy profiles (Figures 5B, 5C, S5B, and S5C). Interestingly,
the loss of Skp2 in Mst1/2 or WW45 KO mice resulted in a
dramatically decreased hepatocyte proliferation rate, a smaller
liver mass, lower liver-to-body weight ratios, and fewer liver
tumors (Figures 5F–5I and S5F–S5I). In contrast, the overex-
pression of WT Skp2, which is mainly located in the nucleus,
dramatically decreased the level of nuclear p27 and resulted
in significantly lower numbers of polyploid cells in both WT and
Skp2 KO livers. However, the overexpression of activated
Skp2 (KLKL), which is mainly located in the cytoplasm, resulted
in only a slightly reduced p27 level (Figure 3K) and thus had no
significant effect on the cell polyploidy profiles (Figures 5D, 5E,
S5D, and S5E). Based on these observations, we speculated
that cytoplasmic Skp2 in Hippo signal-deficient cells might
also promote polyploidy liver cell division in addition to inducing
p27-mediated cell polyploidy. Indeed, Skp2 KO mice infected
with Ad-Skp2 (KLKL) exhibited a significantly increased number
of BrdU-positive hepatocytes and pHH3-positive hepatocytes,
indicating that more cells enter mitosis for proliferation and divi-
sion (Figures 5J and 5K). Consistently, Skp2 KO mice infected
with Ad-Skp2 (KLKL) had a larger liver mass and greater liver/
body weight ratios than control mice that received Ad-GFP
(Figure 5L). Furthermore, the expression of Ad-Skp2 (KLKL) in
HepG2 cells pretreated with Skp2 siRNA (siSkp2) significantly
increased its colony formation rate compared with Ad-GFP-in-
fected control cells (Figure 5M). These results suggested that
cytoplasmic Skp2 promotes polyploidy cell proliferation and
division (Figure 5N).
Cytoplasmic Skp2 Degrades FoxOs to Enhance
Polyploid Cell Proliferation and Division
The data above suggested that cytoplasmic Skp2 might have
other downstream effectors to regulate cell proliferation and liver
size. Previous studies have shown that, in contrast to nuclear
Skp2, which targets nuclear p27 as shown above, cytoplasmic
Skp2 has a distinct set of substrates, including forkhead box O
(FoxO) transcription factors, which are important pro-apoptotic
transcription factors that block cellular proliferation, promote
cell death, and drive cells into a quiescent state (Huang et al.,
2005). Indeed, we found that, compared with WT controls, the
total protein levels of FoxO1/3 and the mRNA expression levels
of the FoxO1/3 target genes, such as Sod2, Catalase, G6pase,
Pepck, Ang2, Fasl, Bnip3, Ccng2, and Igfbp1, were dramatically
reduced in Mst1/2 DKO and Yap Tg livers, indicating the attenu-(H and I) H&E staining of the liver sections from Skp2 KO mice infected with Ad-G
quantification of hepatocytes from the indicated mice using FACS (n = 3) (H, low
(J and K) IHC staining of BrdU or pHH3 (J) and the quantification of BrdU- or pHH3
Ad-GFP or Ad-Skp2 (KLKL) (n = 3). Scale bars, 20 mm.
(L) The representative liver sizes and liver-to-body weight ratios (n = 5) of Skp2 K
(M) A representative image of the clonogenic assay and the quantification of cl
Ad-Skp2 (KLKL).
(N) A proposed working model for acetylated Skp2 promoting liver polyploidy ce
Data were assessed by Student’s t test and represented as mean ± SD. ns, not s
indicated groups. See also Figure S5.
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6B, S6A, and S6B). Consistently, the genetic disruption of
Skp2 increased the protein levels of FoxO1 and FoxO3a in
both WT and Mst1/2 DKO mouse livers (Figure 6C). Previous
studies established the mechanism of FoxO inhibition in which
Akt kinases phosphorylate FoxO1 at Thr24, Ser256, and
Ser319, or FoxO3 at Thr32 and Ser253, thereby increasing their
association with 14-3-3 proteins (Tran et al., 2003). This, in turn,
results in the translocation of FoxO proteins from the nucleus
to the cytoplasm, leading to their transcriptional inactivation.
In fact, we found that the increased phosphorylation levels of
FoxO1(S256, T24) and FoxO3a(T32) correlated with enhanced
Akt activity in Mst1/2 DKO and Yap Tg liver lysates (Figures 6D
and S6C). Immunoblotting of sub-cellular fractions or IHC stain-
ing assays further confirmed that, compared with WT controls,
the FoxO1/3 protein levels were dramatically reduced in the nu-
clear fractions of Mst1/2 DKO or Yap Tg liver cells (Figure 6E, 6F,
and S6D), and the total protein level and sub-cellular distribution
of FoxO1/3 were restored to relatively normal levels in Mst1/2
DKOYap+/- liver cells (Figures 6E and 6F). Consistently, inhibition
or genetic disruption of Akt reduced the FoxO1/3 phos-
phorylation levels and restored FoxO1/3 protein levels and the
sub-cellular distribution in Mst1/2 DKO and Yap Tg livers (Fig-
ures 6D, 6G, and S6C). Furthermore, Skp2-mediated FoxO
ubiquitination was remarkably enhanced in cells overexpressing
Yap, while Akt inhibition attenuated this effect (Figures 6H and
6I). Based on these results, we speculated that cytoplasmic
Skp2-mediated FoxO1/3 degradation might be required for
Hippo signal-deficient polyploid cell survival and proliferation.
To examine this possibility, we reintroduced the non-degradable
form of FoxO1(S256A) in Mst1/2 DKO or Yap Tg livers
using adenoviral vectors, Ad-FoxO1(S256A). Importantly, Ad-
FoxO1(S256A) greatly blocked cell proliferation, enhanced cell
apoptosis, and reduced liver mass compared with those in con-
trol mice receiving Ad-GFP (Figures 6J, 6K, and S6E). Notably,
Ad-FoxO1(S256A) abrogated the Ad-Skp2 (KLKL)-driven Skp2-
deficient liver overgrowth (Figure 6L). These data indicated that
the loss of Hippo signaling promotes polyploid cell division and
oncogenesis, at least in part, through Skp2-mediated FoxO1/3
degradation (Figure 6M).
Yap-Akt-Skp2 Signaling Is Implicated in Human HCC
Development
The data above demonstrated that the loss of Hippo signaling
in the liver resulted in the cytoplasmic retention of both Skp2
and FoxO through the activation of Akt, which promotes Skp2-
mediated FoxO degradation, thereby enhancing p27-induced
polyploid cell division, genomic instability, and oncogenesis.FP, Ad-Skp2 (WT), or Ad-Skp2 (KLKL) (H, upper panel) and the DNA content
er panel, and I). Scale bars, 20 mm.
-positive cells (K) in liver sections from Skp2 KOmice infected with adenovirus
O mice infected with Ad-GFP or AD-Skp2 (KLKL).
ones per well for Skp2-knocked down HepG2 cells infected with Ad-GFP or
ll proliferation.
ignificant (p > 0.05), *p < 0.05, **p < 0.01, ***p < 0.001 compared between the
Figure 6. Yap Promotes Polyploid Cell Division via Skp2-Mediated FoxO Degradation
(A and B) Immunoblot analysis of FoxO1, FoxO3a, and GAPDH (A) and qPCR analysis of FoxO target genes (B) in liver of WT or Mst1/2 DKO mice.
(C) Immunoblot analysis of FoxO1, FoxO3a, Mst1, Mst2, Skp2, and GAPDH in WT, Mst1/2 DKO, Skp2 KO, orMst1f/fMst2f/fSkp2 KO Alb-Cre (TKO) liver lysates.
(D) Immunoblot analysis of p-FoxO1 (S256), p-FoxO1/3 (T24/T32), p-Akt, p-Yap, FoxO1, FoxO3a, Akt, Yap, andGAPDH in liver lysates ofWT orMst1/2 DKOmice
treated with vehicle control (CTR) or Akt inhibitor MK2206.
(legend continued on next page)
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Figure 7. Disruption of Akt Function Atten-
uates Liver Tumor Formation in Mst1/2
DKO Mice
(A and B) Representative liver pictures and the
liver-to-body weight ratios of Mst1/2 DKO mice
treated with the Akt inhibitor MK2206 (n = 5) (A) or
of WT, Akt1 KO, Mst1/2 DKO, or Mst1/2 Akt1 TKO
mice (n = 5) (B).
(C) A representative liver picture and the quantifi-
cation of tumor number fromWT, Akt1 KO, Mst1/2
DKO, or Mst1/2 Akt1 TKO mice (n = 6).
(D and E) A representative liver picture and
the quantification of the size and number of
liver tumors (n = 6) of 5-month-old Mst1/2 DKO
mice treated with vehicle or the Akt inhibitor
MK2206.
(F) A proposed working model for the disruption
of Akt function attenuating liver tumor formation
in Mst1/2 DKO mice.
Data were assessed by Student’s t test and
represented as mean ± SD. ***p < 0.001
compared between the indicated groups. ND,
non-detectable.Importantly, the inhibition or genetic disruption of Akt resulted
in significantly reduced p27 levels, hepatocyte polyploidy, and
decreased liver-to-body weight ratios for Mst1/2 DKOmice (Fig-
ures 4I–4O, 7A, and 7B). We observed that the loss of Akt1 in
Mst1/2 DKO mice resulted in a significantly lower incidence of
HCC in old age (Figure 7C). Consistently, Mst1/2 DKO mice
that have been treated with the Akt inhibitor MK2206 exhibited
a significant decrease in the size and number of tumors, which
correlated with the reduced cytoplasmic Skp2 levels in liver tis-
sues compared with control animals (Figures 7D–7F, S4E, and
S4F). We then examined 60 pairs of liver-derived tumorous
and adjacent non-tumorous tissues. Yap activation was associ-
ated with decreased FoxO1/3, increased Skp2 acetylation, and
Akt phosphorylation in tumorous tissues compared with those
in adjacent noncancerous tissues (Figures 8A–8C and S7A).
These results suggested that Yap-Akt-Skp2 signaling is associ-
ated with human HCC development.
The examination of the tissue microarray of human liver tu-
mors and adjacent non-tumorous tissues (n = 94) by IHC staining
revealed that the expression levels of Yap and Skp2 were higher
in cancer tissues than in adjacent noncancerous liver tissues
(Figure S7B). Nuclear Yap expression and cytoplasmic Skp2
expression were primarily increased in cancer tissues compared
with those in adjacent noncancerous tissues, and were associ-(E and F) Immunoblot analysis of the cell fractions (E) or IHC staining (F) of FoxO
(DKO Yap+/–), or Yap Tg mice. Scale bars, 20 mm.
(G) Immunoblot analysis of FoxO1, FoxO3a, a-tubulin, or PARP in the cytoplasmi
tissues.
(H and I) Immunoassay of the ubiquitination of FoxO1 (detected with anti-Myc)
ubiquitin, Flag-tagged FoxO1, HA-tagged Yap, and HA-tagged Skp2 (H) with or
(J) Quantification of BrdU- or TUNEL-positive cells in the liver sections from Mst
(K and L) The representative liver sizes and liver-to-bodyweight ratios ofMst1/2 DK
mice infected with adenovirus Ad-GFP, Ad-FoxO1(S256A), Ad-Skp2(KLKL), or A
(M) A proposed working model for Yap promoting polyploid cell division via Skp
Data were assessed by Student’s t test and represented as mean ± SD. *p
See also Figure S6.
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Furthermore, increased nuclear Yap expression in cancer tis-
sues was associated with enhanced cytoplasmic Skp2 expres-
sion (Figure 8H, R2 = 0.3724, p < 0.0001). Although there was
no significant association between Yap or Skp2 expression
and sex or age (Table S1), there was a positive correlation be-
tween the nuclear Yap expression or cytoplasmic Skp2 expres-
sion and pathological grade (Table S1). In addition, Kaplan-Meier
survival analysis revealed that the survival time for patients with
high nuclear Yap expression was obviously shorter than those
with low Yap expression (p = 0.0275). Similarly, the cytoplasmic
Skp2 expression level had a negative correlation with survival
(p = 0.0185). Thus, we concluded that there is a close connection
between these two proteins in human HCC development, and
that the inhibition of Akt activity may be a promising therapeutic
strategy to treat HCC resulting from the loss of Hippo signaling.
DISCUSSION
How diploid organisms develop polyploid cells remains largely
unknown. Herein, we report that Hippo signaling maintains
liver cell ploidy in a p53-independent manner. We found that
Hippo signal deficiency or Yap activation turn on Akt signaling,
thereby activating the acetyltransferase p300 to promote Skp21 or FoxO3a of liver cells from WT, Mst1/2 DKO,Mst1f/fMst2f/f YAP +/flAlb-Cre
c and nuclear fractions of WT, Mst1/2 DKO, Akt1 KO, or Mst1/2 Akt1 TKO liver
in the lysates of 293T cells expressing various combinations of Myc-tagged
without Akt inhibitor MK2206 treatment.
1/2 DKO mice infected with Ad-GFP or Ad-FoxO1(S256A) (n = 3).
O infectedwith adenovirus Ad-GFP or Ad-FoxO1(S256A) (n = 5) (K) or Skp2 KO
d-FoxO1(S256A) plus Ad-Skp2(KLKL) (n = 5) (L).
2-mediated FoxO degradation.
< 0.05, **p < 0.01, ***p < 0.001 compared between the indicated groups.
Figure 8. Yap-Akt-Skp2 Signal Is Implicated in Human HCC Progress
(A) A representative image of H&E staining and the IHC analysis of p-Yap, p-Akt, Skp2, or FoxO1 in the liver sections of adjacent non-tumorous livers (N) or HCC
tissues (T) isolated from one patient. Scale bars, 50 mm.
(B and C) Western blot analysis of ace-Skp2, Skp2, FoxO1, FoxO3a, p-Akt, Akt, p-Yap, Yap and GAPDH in HCC tissue (T) and adjacent non-tumorous liver tissue
(N) isolated from one patient. Six representative paired samples are shown (B). See Figure S7A for the remaining 54 paired samples. For the detection of ace-
Skp2, the loading of immunoprecipitates was normalized according to the levels of total Skp2. The intensities of the immunoblot bands were quantified using
ImageJ software. A heatmap representation of the ratio of the relative expression of the proteins p-Yap, FoxO3a, FoxO1, ace-Skp2, or p-Akt in the T and N
samples from one patient. Clustering was performed by using Pearson correlation metric and centroid linkage (C).
(D–G) Scatterplot analysis of the immunoreactive score (IRS) of the nuclear Yap (D and F) or the cytoplasmic skp2 (E and G) impaired liver cancer and adjacent
non-cancer paraffin tissue sections or in different tumor stages from the tissue microarray of human liver cancer. IRS scores of 0–1 indicate negative; scores of
2–3 indicate mild; scores of 4–8 indicate moderate; scores of 9–12 indicate strongly positive. A total of 94 paired samples are shown. The data were assessed by
Student’s t test and are represented as the mean ± SD.
(legend continued on next page)
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acetylation, stabilization, and cytoplasmic retention, which re-
sults in p27 hyper-accumulation and induces cell polyploidy.
As a result of Skp2 cytoplasmic retention, the pro-apoptotic
factors FoxO1/3 are overly degraded and thereby promote poly-
ploid cell division, genomic instability, and oncogenesis. More-
over, the inhibition or genetic disruption of Akt or p27 reduces
cell polyploidy and oncogenesis, whereas the depletion of
Skp2 has no significant effect on Mst1/2-null cell polyploidy,
but does prevent polyploid cell division and abrogates liver over-
growth and tumorigenesis. These data indicate that Hippo-Skp2
signaling prevents genomic instability through two possible
mechanisms: maintaining Skp2-mediated p27 degradation in
the nuclei to limit polyploidy formation or preventing Skp2-medi-
ated FoxO1/3 degradation in the cytosol to block polyploidy cell
division, thereby limiting the risk of genomic instability, aneu-
ploidy, and tumorigenesis.
Our current study demonstrates that the sustained activation
of Yap overrides the p27-mediated checkpoint, at least in part,
through the degradation of FoxO family proteins, allowing poly-
ploid cells to proliferate inappropriately with mitotic defects and
resulting in centrosome amplification, genomic instability, and
cell oncogenesis. In fact, p27 plays a dual role in the regulation
of the cell cycle and genomic stability in the mouse liver (Car-
rano et al., 1999; Kossatz et al., 2004; Nakayama et al., 2004;
Serres et al., 2012). For cell-cycle control, elevated p27 arrests
the cell cycle via the inhibition of CDKs to prevent cell division. In
contrast, increased p27 results in mitotic defects and promotes
endoreduplication cycles to induce cell polyploidy and genomic
instability in mouse livers, while a loss of p27 reduces cell
polyploidy, thereby maintaining genomic stability. In addition,
p27 has long been known to be an assembly factor for cyclin
D/Cdk4 complexes (LaBaer et al., 1997). Thus, elevated p27 in
polyploid cells might increase Cdk4 activity and promote cell di-
vision, aneuploidy, and genomic instability, thus contributing to
the development of cancer. In the context of the much higher
fraction of polyploid cells in Mst1/2 DKO liver tissues, it is not
surprising to observe that the loss of p27 in Hippo-deficient
livers resulted in decreased cell polyploidy and a significantly
reduced number and volume of tumor size. Thus, these data
support a key role of p27 expression in the tumorigenesis
of polyploid organs, such as livers with deregulated Hippo
signaling.
Previous studies have shown that tetraploid cells arrest their
cell cycle in a p53-dependent manner. Hippo tumor suppressor
pathway Lats1/2 kinases were shown to induce tetraploid cell-
cycle arrest by preventing Mdm2-mediated p53 degradation
(Aylon et al., 2006; Iida et al., 2004; McPherson et al., 2004).
However, we found that Yap overexpression or the deletion
of Yap inhibitory components such as WW45, Mst1/2, and
Lats1/2 in mouse livers results in highly increased p53 expres-
sion and activity. Moreover, the combined losses of Hippo
signaling and p53 lead to greatly increased polyploidy with mul-
tiple nuclei and results in a higher incidence and earlier onset of
liver tumors. Thus, the increased p53-mediated response might(H) The IRS of nuclear Yap and the cytoplasmic Skp2 of liver cancer sections from
linear regression t test.
(I and J) Kaplan-Meier plot of overall survival of patients with HCC stratified by hig
levels. A log-rank test is used for statistical analysis. See also Figure S7 and Tab
682 Cancer Cell 31, 669–684, May 8, 2017be a potent negative feedback loop in response to increased cell
polyploidy upon the disruption of Hippo signals. Alternatively,
other effectors downstream of Yap that positively augment the
p53 response possibly exist. These results suggested that Hippo
signaling might play a dual role in p53 regulation, positively as a
blockage of Mdm2-mediated p53 degradation by Lats1/2 but
negatively as an inhibitor of the Yap-induced p53 response. It
will be of particular interest to determine how Yap regulates
p53 activity in future studies.
In addition, a previous study showed that tetraploid cells have
lower Rho activity, which is mainly due to increased Rac activa-
tion in the presence of excess microtubules nucleated by extra
centrosomes (Ganem et al., 2014). Restoring Rho activity en-
ables the cell to bypass G1 arrest. Consistently, enhanced cell-
matrix adhesion, which activates Rho, is reported to reduce
the G1 arrest of tetraploid cells. Interestingly, our previous
work demonstrated that the Hippo kinases Mst1 and Mst2 are
required for Rac activation (Geng et al., 2015). Thus, whether
the reintroduction of active Rac induces the G1 arrest of tetra-
ploid cells is an interesting open question. Moreover, a previous
study reported that Mst1 limits the kinase activity of aurora B to
promote stable kinetochore-microtubule attachment (Oh et al.,
2010). Thus, there might be other effectors downstream of
Hippo signaling that mediate polyploidy. In conclusion, our re-
sults reveal that the modulation of the Hippo signaling pathway
orients hepatocytes into a specific cell-cycle program, leading
to the generation of diploid or polyploid cells. It is of interest to
determine whether Hippo signaling is also involved in the regula-
tion of other polyploid cell types such as megakaryocyte
polyploidization.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Mice
The miceMst1fl/fl,Sav1fl/fl, Lats1fl/fl, Lats2fl/flandYap1fl/fl (from R. L. Johnson), Mst2fl/fl(Zhou et al., 2009),Skp2 KO (Nakayama et al.,
2000)and Yap1S127A transgenic mice(Camargo et al., 2007)were obtained as indicated.Wild-type C57BL/6, Tg(Alb-Cre)21Mgn/J,
Trp53lox/lox, B6.129P2-Akt1tm1Mbb/J and 129-Cdkn1btm1Mlf/J (p27 KO) mice were originally purchased from the Jackson
Laboratory.See ‘‘Key Resources Table’’ for details. All mice were maintained under specific pathogen-free conditions at the Xiamen
University Laboratory Animal Center. These mouse experiments were approved by the Institutional Animal Care and Use Committee
and were in strict accordance with good animal practice as defined by the Xiamen University Laboratory Animal Center.
Cell Lines and Cell Culturing
The 293T and HepG2 cell lines (from the American Type Culture Collection) were tested for mycoplasma contamination and were
found to be negative, then were cultured in DMEM (invitrogen, Carlsbad, CA, USA)supplemented with 10% FBS and 1 x peni-
cillin-streptomycin. Mouse primary hepatocytes were isolated by the two-step liver perfusion method as above described. The cells
were plated in 24-well gelatin-coated plates (8 x 104) in Williams’ Medium E (Invitrogen) containing 10% fetal bovine serum,
100 U/mlpenicillin /streptomycin and 1 3 107 M insulin, and cultured at 37 C with 5% CO2.e4 Cancer Cell 31, 669–684.e1–e7, May 8, 2017
Human Liver and HCC Samples
Human samples for Western blot analysis were obtained with informed consent from human tissue banks of Zhongshan Hospital of
Xiamen University. Regarding correlation analysis, we took binary logarithm ratio of the proteins expression in the cancer tissue and
the matched paracancerous tissue. Since the distribution of log-ratio do not follow Gaussian distribution, we used ‘‘Spearman rank
correlation coefficient’’ to evaluate the correlation of the log-ratios of paired proteins among p-Yap, p-Akt, Ace-skp2, FoxO1 and
FoxO3a. Then the significance of correlation coefficients was tested against the null hypothesis of zero-correlation, using two-sided
t-test. We adjusted the pvalue using ‘‘Benjamin & Hochberg ‘‘method and set 0.05 to the significance level. The tools for correlation
analysis are available from R version 3.1.2, which can be downloaded from https://www.r-project.org. Paired cancer and adjacent
non-cancer paraffin tissue sections (HLiv-HCC180Sur-05 for HCC) were purchased from Shanghai Outdo Biotech (Shanghai, China).
The immunoreactive score (IRS) gives a range of 0–12 as a product of multiplication between positive cells proportion score (0–4) and
staining intensity score (0–3). The IRS, 0-1, negative; 2-3, mild; 4-8, moderate; 9-12, strongly positive (Fedchenko and Reifenrath,
2014). All experiments were performed with the approval of the Xiamen University Review Board. Snap-frozen biopsies from spec-
imens of normal liver tissue (distant from the tumor) and HCC were collected. The diagnosis of HCC or normal liver was confirmed
based on histological findings by independent pathologists.
METHOD DETAILS
Hepatocyte Isolation and Ploidy Measurement
Mouse primary hepatocytes were isolated by the two-step liver perfusion method and cell ploidy was analyzed by flow cytometry.
Briefly, the mouse was anesthetized with intraperitoneal injection of xylazine (10 mg/kg body weight) and ketamine (100 mg/kg body
weight). The abdomen was then cut open, and the portal vein was catheterized. The liver was first perfused in situ with D-Hank’s
buffered solution (containing 0.5 mM EGTA, pre-warmed to 37C) for 8-10 min with the inferior vena cava cut for drainage and
then perfused for 5 min with 0.12 PZ-U/ml collagenase perfusate (containing 2 mM Ca2+). The livers were extirpated and transferred
into plates filled with DMEM at 4C. The hepatic capsules were torn, and the livers were gently shaken to help the cells detach. The
cell suspension was collected and filtered through 70 mm cell strainers (BD Falcon, Bedford, USA), resuspended in Percoll/
DMEM/PBS (1:1:0.3) mixture and centrifuged at 50g for 15 min at RT. Cell viability was examined by the Trypan blue exclusion
test (generally >90%). Purified hepatocytes were then washed with PBS and fixed with 70% ice-cold ethanol overnight. Cells
were then washed with 5ml PBS and resuspended in 0.5ml of 0.25mg/ml RNase A and 10ug/ml propidum iodide in PBS for fluores-
cence-activated cell sorting (FACS) analysis using flow cytometer BD LSRortessa (BD biosciences). Flow cytometry data were
analyzed using FlowJo software (Treestar, Ashland, USA). The polyploidy profile were quantified and plotted from three mice per
genotype.
Correlation Analysis of Cell Size, Nucleus Size and DNA Content
The correlation of cell size, nuclear size and ploidy was assessed by immunefluorescence staining and FACS approaches. Hepato-
cytes in liver sections were labeled with DAPI (recognition of nucleus, blue) and antibody against b-catenin (a marker usually used to
outline cell membrane, green, and 1:100 dilution, Abcam, ab6301). The areas of cell (cell size) and DAPI positive compartment (nu-
cleus) were imaged with Zeiss LSM 780 and quantified by ImageJ software. In addition, the intensity value of forward-scattered light
(FSC) of FACS is proportional to cell size and the intensity value of Hoechst 33342 dye staining is used tomeasure DNA content. Flow
cytometry data were analyzed using FlowJo software (Treestar, Ashland, USA).
MEF Preparation and Infection
Embryos from timed pregnancies were harvested between E12.5-E14.5. Heads, livers, and blood clots were removed and the rest of
tissues were minced and put into 1ml Trypsin (Gibco, CA, USA) for 10 min at 37C. The tissue and Trypsin mixture was pipetted up
and down several times and the dissociated cells were cultured in DMEM (invitrogen, Carlsbad, CA, USA) containing 10% fetal
bovine serum (FBS) and 1 3 penicillin/streptomycin. Cells were split every 3-4 days during early passages, and MEFs at passage
2 or 3 were used for infection. Parallel infection with adeno-Cre or adeno-GFP were used to delete Lats1 and Lats2 or Yap in
MEFs containing floxedLats1/2 or Yap.
Hydrodynamic Gene Delivery
Hydrodynamic delivery of 100mg of pCMV-Yap-mCherry or control mCherry plasmid in 2 ml of Ringer’s solutions (147 mMNaCl,
4 mMKCl, 1.13 mM CaCl2) were done via tail vein injections within 5 s.
Generation of Recombinant Adenovirus
Recombinant adenovirus was generated using standard techniques. Briefly, the myr-Akt1, Skp2 (WT), Skp2(KLKL) and FoxO1
(S256A) cDNA were subcloned into the multicloning site of the AdTrack-CMV shuttle vector, which contains a GFP as a reporter
gene. The Myr-Akt1, Skp2 (WT) and Skp2 (KLKL) cDNA were inserted between the KpnI–XhoI restriction sites; FoxO1(S256A)
cDNAwas inserted between the KpnI–SalI restriction sites. The shRNA against p27 (Shp27) oligo pairs were annealed and subcloned
into the polylinker region of the pLL3.7 vector and then cut by XhoⅠ and XbaⅠ restriction enzyme. The fragment containing Shp27 was
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vector, which contains a GFP as a reporter gene. The resultant plasmid was linearized by digestion with PmeI endonuclease
and cotransformed into Escherichia coli BJ5183 cells with the AdEasy-1 adenoviral plasmid, which contains the entire genomic
sequences of adenovirus serotype Ad5, except the nucleotides encompassing the E1 and E3 genes. Recombinant bacteria
were selected by kanamycin resistance and the recombination was confirmed by a PacI endonuclease restriction analysis. The
Ad-GFP was constructed similarly. Subsequently, the verified clone was amplified, linearized with PacI and transfected into
HEK293A packaging cells. The recombinant adenovirus was released from the cells by four freeze–thaw–vortex cycles 14–
20 days post transfection, amplified by further rounds of infection of HEK293A packaging cells and purified by CsCl ultracentrifuga-
tion. Stocks of purified adenovirus were titred by counting the number of plaque-forming units. The recombinant adenoviruses (2 3
109pfu in 200 ml PBS) were injected into 6- to 8-week-old male mice via the tail vein.
shRNA and Lentiviral Infection
The shRNA-targeted sequencesagainst p27 andSkp2were synthesized. Oligo pairs were annealed and subcloned into the polylinker
region of the pLL3.7 vector. Lentivirus was produced by co-transfecting 293T cells with the shRNA in the vector pLL3.7, VSV-G and
D8.9 plasmids using Lipofectamine 2000 (Invitrogen). Viral supernatant was harvested at 48-72 h post-transfection, passed through a
0.45 mm filter, diluted 2:3 with fresh medium containing 8 mg/ml polybrene and used to infect the target cells at 80% confluence. Pro-
tein expression was visualized by immunoblotting.
Generation of AAV-Shp27 Virus
The shRNA-targeted p27 sequence and scramble control sequence were synthesized. Oligo pairs were annealed and subcloned into
the pscAAV-GFP vector (Addgene#32396). 293 T cells were co-transfected with scAAV shRNA or control plasmid, adenovirus helper
plasmid PXX6 and AAV8 helper plasmid p5E18-VD28. Cells were harvested 60 hr post transfection. The crude virus were released
from 293T cells after 3 times of freezing and thaw, and then further purifiedwith chloroform treatment and PEG8000-(NH4)2SO4 parti-
tion. The virus fraction were dialyzed in PBS solution and concentrated by Amicon Ultra centrifugal filter. The AAV titer was deter-
mined by RT-PCR using primers against the CMV promoter on the AAV vector. Mice were infected with AAV virus at 1x1011 virus
copies per mouse via tail vein injection.
Real-Time Quantitative PCR
One microgram of total RNA from the liver tissue or cells was reverse transcribed with oligo dT and Superscript III reverse transcrip-
tase (Invitrogen). Real-time quantitative PCR was performed using a BioRadiQ SYBR Green Supermix kit and the BioRadiCycleriQ
system (BioRad, Hercules, CA, USA). All runs were accompanied by the internal control Gapdh gene. The samples were run in trip-
licate and normalized to Gapdh using a DD cycle threshold-based algorithm, to provide arbitrary units representing relative expres-
sion levels. Each graph is representative of at least three independent experiments.
SDS-PAGE and Immunoblot Analysis
Proteins were separated by SDS-PAGE, were transferred onto a PVDF membrane and then were identified by immunoblot analysis
with the appropriate primary antibodies at a dilution of 1:1,000. Horseradish peroxidase–conjugated antibody to rabbit IgG (7074) or
to mouse IgG (7076) (1:3,000 dilution for each) were from Jackson ImmunoResearch Laboratories. The protein bands were visualized
with a SuperSignal West Pico Kit according to the manufacturer’s instructions (Thermo Fisher Scientific Pierce).
Immunofluorescence Staining
The cells were washed three times with PBS andwere fixed for 15min at room temperature with 4% (vol/vol) paraformaldehyde, after
which additional immunofluorescence staining was applied. The primary antibodies,anti-HA (1:250 dilution; Santa Cruz sc-7392),
anti-Flag (1:500 dilution; Sigma), anti-a-tubulin (1:250dilution; Cell signaling, 2125), anti-Skp2 (1:100 dilution; Proteintech, 15010-
1-AP), anti-g-tubulin (1:250 dilution; Abcam ab11316), anti-Centrin1 (1:250 dilution; Abcam ab11257) or anti-g-tubulin (1:200 dilution;
proteintech 15176-1-AP) were used.Fixed cells were rinsed with PBS and then were incubated for 10 min on ice with 0.2% Triton
X-100 and 0.2% BSA in PBS. Following permeabilization, nonspecific binding in the cells was blocked by incubation for 30 min at
room temperature with 0.02% Triton X-100 and 5% BSA in PBS and cells were incubated for 1 hr with specific primary antibodies
(identified above). After three washes with PBS, the cells were incubated for another 1 hr with secondary antibodies (Alexa Fluor 488–
conjugated anti–mouse IgG (A21202), Alexa Fluor 488–conjugated anti–rabbit IgG (A21206) or Alexa Fluor 555–conjugated
anti–mouse IgG (A31570) (all from Invitrogen). Subsequently, the cells were washed three times with PBS and were mounted with
Vectashield mounting medium containing DAPI. All images were collected with a confocal microscope (Zeiss LSM 780).
Immunohistochemistry
The tissue specimens were fixed overnight in 10% neutral-buffered formalin and then were dehydrated in increasing concentrations
of isopropyl alcohol, followed by clearing of alcohol by xylene. The specimens were subsequently embedded in paraffin wax in cas-
settes for facilitation of tissue sectioning. Standard staining with hematoxylin and eosin was performed on sections 5 mm in thickness
from each specimen block. For immunohistochemistry, liver sections were deparaffinized and incubated in citrate buffer at 95C for
40 min for antigen retrieval and then incubated overnight at 4 Cwith the primary antibodies including anti-BrdU (1:100 dilution, life
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(1:100 dilution, proteintech, 15010-1-AP), anti-p27 (1:100 dilution, Cell signaling 2552), anti-Foxo1 (1:100 dilution, Cell signaling,
2880), anti-Foxo3a (1:100 dilution, Cell signaling, 12829) and antibody to phosphorylated Akt (1:50 dilution, Cell signaling ,9271s).
After three washes, tissue sections were incubated with biotinylated anti-mouse IgG (1:200 dilution, Vector Laboratories, CA,
USA) for 1 hr at RT and then washed three times, after which streptavidin–horseradish peroxidase conjugates (Vector Laboratories,
CA, USA) were added and the slides incubated for 45min. After three washes with PBS, DAB solution (Vector Laboratories, CA, USA)
was added and the slides were counterstained with haematoxylin.
Clonogenic Assay for the Cell-Survival Experiment
Cells were trypsinized and counted with a hemocytometer. Three milliliters of DMEM full medium containing 500 cells was plated in
each of the three wells in the six-well plate. The cells were maintained at 37 C for 7 days to allow the formation of colonies and were
then stained with 0.5% crystal violet (Sigma-Aldrich) in absolute methanol.
Treatment of Mice with Akt Inhibitor MK2206
MK-2206 (obtained from Selleck Chemicals) was prepared in 30% (v/v) Captisol (CyDex Pharmaceuticals). Mice were randomized
into two groups: vehicle control or MK-2206-treated. For short-term treatment, 8-week-old WT or Mst1/2 DKO mice were adminis-
tered at a dose of 200 mg/kg by oral gavage three times per week for 2 weeks. For the long-term therapy, 12-week-old WT or Mst1/2
DKO mice were administered at a dose of 200 mg/kg by oral gavage three times per week for 8 weeks. The control group received
vehicle only. Liver tissues used for RNA purification, protein extraction or histology were harvested at the indicated times.
QUANTIFICATION AND STATISTICAL ANALYSIS
All data are representative of at least three independent experiments. All statistical analyses were performed using Prism5
(GraphPad). The data are presented as the mean± SD and Student’s t test was used for comparisons between two groups. Survival
data was analyzed using Kaplan–Meier statistical method. The ratio of the relative expression of the indicated proteins from the tumor
patients was plotted and applied with the linear regression ttest. A p value 0.05was considered statistically significant. In the graphed
data *, **, and *** denote p values of < 0.05, 0.01 and 0.001, respectively.Cancer Cell 31, 669–684.e1–e7, May 8, 2017 e7
